Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016".

[1]  N. Schultz,et al.  NEXT GENERATION SEQUENCING OF NON‐MUSCLE INVASIVE BLADDER CANCER REVEALS POTENTIAL BIOMARKERS AND RATIONAL THERAPEUTIC TARGETS: PD48‐11 , 2017, European urology.

[2]  J. McKenney,et al.  Large nested variant of urothelial carcinoma: a clinicopathological study of 36 cases , 2017, Histopathology.

[3]  M. Babjuk,et al.  Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review. , 2017, European urology.

[4]  T. Ørntoft,et al.  Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study. , 2017, European urology.

[5]  A. Hartmann,et al.  Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder Cancer , 2017, Bladder cancer.

[6]  M. Höglund,et al.  Molecular classification of urothelial carcinoma: global mRNA classification versus tumour‐cell phenotype classification , 2017, The Journal of pathology.

[7]  Maximilian Burger,et al.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. , 2017, European urology.

[8]  T. Kwast,et al.  Analysis of papillary urothelial carcinomas of the bladder with grade heterogeneity: supportive evidence for an early role of CDKN2A deletions in the FGFR3 pathway , 2017, Histopathology.

[9]  G. Guazzoni,et al.  Active surveillance for low‐risk non‐muscle‐invasive bladder cancer: mid‐term results from the Bladder cancer Italian Active Surveillance (BIAS) project , 2016, BJU international.

[10]  Alfred Rademaker,et al.  Genomic characterization of high-risk non-muscle invasive bladder cancer , 2016, Oncotarget.

[11]  Wun-Jae Kim,et al.  How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy? , 2016, Investigative and clinical urology.

[12]  Jonathan I. Epstein,et al.  WHO Classification of of Tumours of the Urinary System and Male Genital Organs , 2016 .

[13]  J. Epstein,et al.  Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder. , 2016, Human pathology.

[14]  M. Fernö,et al.  A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma. , 2015, European urology.

[15]  L. Bégin,et al.  Inverted urothelial carcinoma: a series of 12 cases with a wide morphologic spectrum overlapping with the large nested variant. , 2015, Human pathology.

[16]  Soum D. Lokeshwar,et al.  Impact of 2004 ISUP/WHO classification on bladder cancer grading , 2015, World Journal of Urology.

[17]  O. Cussenot,et al.  Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old , 2015, Virchows Archiv.

[18]  G. Hidas,et al.  Mixed high and low grade bladder tumors--are they clinically high or low grade? , 2014, The Journal of urology.

[19]  S. Jun,et al.  Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder , 2014, Virchows Archiv.

[20]  A. Venyo.  Microcystic Variant of Urothelial Carcinoma , 2013, Advances in urology.

[21]  G. Kristiansen,et al.  An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps , 2013, Histopathology.

[22]  M. Fernö,et al.  Toward a molecular pathologic classification of urothelial carcinoma. , 2013, The American journal of pathology.

[23]  Z. Kos,et al.  Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance , 2013, Virchows Archiv.

[24]  Ju-Han Lee,et al.  CD74 expression is increased in high‐grade, invasive urothelial carcinoma of the bladder , 2013, International journal of urology : official journal of the Japanese Urological Association.

[25]  F. Montorsi,et al.  Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors. , 2011, The Journal of urology.

[26]  J. Epstein,et al.  Large Nested Variant of Urothelial Carcinoma: 23 Cases Mimicking von Brunn Nests and Inverted Growth Pattern of Noninvasive Papillary Urothelial Carcinoma , 2011, The American journal of surgical pathology.

[27]  A. Hartmann,et al.  The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer , 2011, BJU international.

[28]  T. H. van der Kwast,et al.  Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer. , 2010, European urology.

[29]  Samay Jain,et al.  Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma. , 2010, Urology.

[30]  A. Zlotta,et al.  The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading. , 2010, European urology.

[31]  Chin-Chen Pan,et al.  Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. , 2010, American journal of clinical pathology.

[32]  G. Kristiansen,et al.  Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. , 2010, European urology.

[33]  T. H. van der Kwast,et al.  Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study. , 2008, European urology.

[34]  R. Montironi,et al.  Immunohistochemical Evaluation of Global DNA Methylation and Histone Acetylation in Papillary Urothelial Neoplasm of Low Malignant Potential , 2008, International journal of immunopathology and pharmacology.

[35]  T. H. van der Kwast,et al.  FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. , 2007, European urology.

[36]  C. Acar,et al.  Comparison of 1998 WHO/ISUP and 1973 WHO Classifications for Interobserver Variability in Grading of Papillary Urothelial Neoplasms of the Bladder , 2007, Urologia Internationalis.

[37]  V. Paradis,et al.  Aurora-A/STK-15 is a predictive factor for recurrent behaviour in non-invasive bladder carcinoma: a study of 128 cases of non-invasive neoplasms , 2007, Virchows Archiv.

[38]  I. Sesterhenn,et al.  World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .

[39]  D. Nicol,et al.  Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome , 2004, BJU international.

[40]  A. Leong,et al.  Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. , 2004, American journal of clinical pathology.

[41]  A. Marx,et al.  World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs , 2004 .

[42]  V. Reuter,et al.  Nested Variant of Urothelial Carcinoma: A Clinicopathologic and Immunohistochemical Study of 12 Cases , 2003, Modern Pathology.

[43]  J. Baak,et al.  Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. , 2003, The Journal of urology.

[44]  W. Murphy,et al.  Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care. , 2002, The Journal of urology.

[45]  H. Samaratunga,et al.  Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. , 2002, Urology.

[46]  S. Johansson,et al.  Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression. , 2002, The Journal of urology.

[47]  A. Formiconi,et al.  Biologic Differences Between Noninvasive Papillary Urothelial Neoplasms of Low Malignant Potential and Low-Grade (Grade 1) Papillary Carcinomas of the Bladder , 2001, The American journal of surgical pathology.

[48]  J. McKenney,et al.  Morphologic Expressions of Urothelial Carcinoma In Situ: A Detailed Evaluation of Its Histologic Patterns With Emphasis on Carcinoma In Situ With Microinvasion , 2001, The American journal of surgical pathology.

[49]  M. Droller.  Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. , 2001, The Journal of urology.

[50]  D. Bostwick,et al.  Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma , 2000, Cancer.

[51]  J. Cheville,et al.  Flat intraepithelial lesions of the urinary bladder , 2000, Cancer.

[52]  Lawrence D. True,et al.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .

[53]  F. Mostofi,et al.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. , 1998, The American journal of surgical pathology.

[54]  F. Debruyne,et al.  Grading in superficial bladder cancer. (1). Morphological criteria. , 1988, British journal of urology.

[55]  B. Norlén,et al.  Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up. , 2010, Scandinavian journal of urology and nephrology.

[56]  S. Loening,et al.  Superficial bladder cancer: progression and recurrence. , 1983, The Journal of urology.

[57]  J. B. Stern.  Unusual benign bladder tumor of Brunn nest origin. , 1979, Urology.